In other cases, the company might give the executive an upfront--again, large--grant of free shares of company stock.
The company could give executives some free stocks.
The FDA's position is that reductions in personal property's value, even prohibitions on all economically viable uses, and financial expenditures to comply with a regulatory requirement do not necessarily establish a taking, citing various court decisions for support.